Novel α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) potentiator LT-102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia

CONCLUSION: We conclude that LT-102 ameliorates cognitive impairments in a phencyclidine-induced model of schizophrenia by enhancing synaptic function, which could make it a potential therapeutic candidate for CIAS.PMID:38615362 | PMC:PMC11016348 | DOI:10.1111/cns.14713
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Source Type: research